In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.
The company is hoping that consumers will use its platform to manage their health data, to participate in research, and to learn about their own and their family's health risks.
Researchers will study the genetic underpinnings of cancer, heart disease, and respiratory illness by delving into the exome sequencing data from 40,000 Northern Nevadans.
The 4,000-participant study will use a digital enrollment platform and will provide free genetic testing as well as support from doctors and genetics experts.
23andMe's genetic health report is for three BRCA1 and BRCA2 mutations most commonly found in people of Ashkenazi Jewish descent.
The consumer genomics firm says employer benefits programs could expand access to BRCA1/2, Lynch syndrome, and FH genetic testing in the general population.
Researchers constructed family trees with up to 13 million members from public genealogy profiles, but some disagree with their conclusions on the genetics of longevity.
Helix expects its online store will grow this year to include more than 50 genomics apps, including new health products from partners like Geisinger and Mayo.
The company plans to use the additional funds to introduce new genomics app products within its online store this year.
Startup Optra Health has added Alexa and Cortana compatibility to its AI platform to help consumers understand Ancestry.com- and 23andMe-type genetic tests.
In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.
An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.
In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.